Fair Value Measurements (Tables)

3 Months Ended

May 04, 2024

Fair Value Disclosures [Abstract]

Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis

The following table presents financial instruments that are measured at fair value on a recurring basis at May 4, 2024, February 3, 2024 and April 29, 2023:

	Fair Value Measurements
(In thousands)	Level 1		Level 2		Level 3		Total
As of May 4, 2024
Cash equivalents - money market mutual funds	$	40,588	$	0	$	0	$	40,588
Marketable securities - mutual funds that fund     deferred compensation		12,555		0		0		12,555
Total	$	53,143	$	0	$	0	$	53,143
As of February 3, 2024
Cash equivalents - money market mutual funds	$	91,733	$	0	$	0	$	91,733
Marketable securities - mutual funds that fund     deferred compensation		12,247						12,247
Total	$	103,980	$	0	$	0	$	103,980
As of April 29, 2023
Cash equivalents - money market mutual funds	$	29,456	$	0	$	0	$	29,456
Marketable securities - mutual funds that fund     deferred compensation		11,535						11,535
Total	$	40,991	$	0	$	0	$	40,991

Schedule Of Deferred Compensation Plan Liabilities And Related Marketable Securities

The following tables present the balances and activity of the Company’s deferred compensation plan liabilities and related Marketable Securities:

(In thousands)	May 4, 2024		February 3, 2024		April 29, 2023
Deferred compensation plan current liabilities	$	183	$	114	$	1,921
Deferred compensation plan long-term liabilities		12,157		11,639		9,809
Total deferred compensation plan liabilities	$	12,340	$	11,753	$	11,730
Marketable securities - mutual funds that fund deferred compensation	$	12,555	$	12,247	$	11,535

(In thousands)	Thirteen Weeks Ended  May 4, 2024			Thirteen Weeks Ended  April 29, 2023
Deferred compensation liabilities
Employer contributions, net	$	81		$	96
Investment earnings (losses)		323			(3	)
Marketable Securities
Mark-to-market (gains) losses (1)		(308	)		66
Net deferred compensation expense	$	96		$	159

(1) Included in the mark-to-market activity, we recognized unrealized gains of $292,000 and $299,000 related to equity securities still held at May 4, 2024 and April 29, 2023, respectively.